Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Immunology of Infectious Disease News
Immunology of Infectious Disease News is an online resource dedicated to covering the latest research and developments in the field of infectious diseases.
Nanoparticle Vaccine Triggers Interferon-Gamma Production and Confers Protective Immunity against Porcine Reproductive and Respiratory Syndrome Virus
[ACS Nano] Researchers designed and produced a self-assembling nanoparticle vaccine derived from thermophilic archaeal ferritin to combat epidemic porcine reproductive and respiratory syndrome virus.
A Modular Self-Assembling and Self-Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG
[Small] While many studies on booster subunit vaccines have concentrated on recombinant proteins, here scientists developed a novel modular peptide-based subunit vaccine platform that was flexible, cold-chain independent and customizable to diverse circumstances and populations.
Vaccination Prior to SARS-CoV-2 Infection Does Not Affect the Neurologic Manifestations of Long COVID
[Brain Communications] Researchers investigated whether vaccination prior to infection altered the subsequent neurologic post-acute sequelae of SARS-CoV-2 infection.
The Identification of a SARS-CoV2 S2 Protein Derived Peptide with Super-Antigen-Like Stimulatory Properties on T-Cells
[Communications Biology] Investigators identified a region in the SARS-CoV-2 S2 spike protein with sequence homology to bacterial super-antigens.
What You Need to Know About HMPV As China Sees Rise in Cases
[ABC News] Chinese health officials are reportedly monitoring an increase in cases of human metapneumovirus (HMPV).
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
[ModeX Therapeutics, Inc.] ModeX Therapeutics, Inc. announced it has been awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the US Department of Health and Human Services.
Infectious Agents in the Pathogenesis of Autoimmune Rheumatic Diseases
[Translational Research] The authors provide a brief review of the role of viruses in the outset and development of autoimmune rheumatic diseases.
Human Respiratory Organoids Sustained Reproducible Propagation of Human Rhinovirus C and Elucidation of Virus-Host Interaction
[Nature Communications] Researchers sought to develop an organoid-based system to reproducibly propagate HRV-C, and characterized virus-host interaction using respiratory organoids.
Incidence and Outcome of Hepatitis D Virus Infection in People with HIV in the Era of Tenofovir-Containing Antiretroviral Therapy
[Clinical Infectious Diseases] Researchers investigated the incidence of hepatitis D virus infection and its clinical impact in hepatitis B virus-coinfected people with HIV in the era of tenofovir-containing antiretroviral therapy.
Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents
[Journal of The American Chemical Society] Investigators demonstrated the value of a second generation of cysteine protease inhibitors that comprised a single agent that acted on both human cathepsin L and SARS-CoV-2 3CL protease.
Phenotypic Evolution of SARS-CoV-2 Spike during the COVID-19 Pandemic
[Nature Microbiology] Scientists generated a panel of recombinant viruses carrying different spike proteins from 27 variants circulating between 2020 and 2024 in the same genomic background.
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells
[Inflammation] Scientists investigated the interaction of SARS-CoV-2 spike protein with human endothelial cells from aortic and pulmonary microvascular origins, cultured under physiological flow conditions.
Immunology of Infectious Disease News was founded to keep the scientific community current with the latest developments in infectious disease research. We feature high-impact publications, news, jobs, and events focused on immune responses to and the development of treatments for infectious diseases such as COVID-19, HIV, hepatitis, tuberculosis, influenza, and malaria.
